1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 17 Hits
  • 検索条件 : 絞込み (MeSH = Carcinoma, Non-Small-Cell Lung* / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 LK-2(RCB1970) Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
ヒト・動物細胞 II-18(RCB2093) Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
ヒト・動物細胞 A549(RCB0098) , HCT116(RCB2979) Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
ヒト・動物細胞 EBC-1(RCB1965) Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.
ヒト・動物細胞 293T(RCB2202) Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
実験動物マウス RBRC09497 Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
ヒト・動物細胞 PC-14(RCB0446) Suppression of non-small-cell lung cancer A549 tumor growth by an mtDNA mutation-targeting pyrrole-imidazole polyamide-triphenylphosphonium and a senolytic drug.
ヒト・動物細胞 A549(RCB0098) Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer.
ヒト・動物細胞 Lu99(RCB1900) , LU65(RCB1967) Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
ヒト・動物細胞 Ba/F3(RCB0805) Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
ヒト・動物細胞 PC-9(RCB4455) MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements.
ヒト・動物細胞 PC-9(RCB4455) , Jurkat(RCB3052) A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.
ヒト・動物細胞 Ba/F3(RCB0805) , WEHI-3(RCB0035) Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.
ヒト・動物細胞 Ba/F3(RCB0805) Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
ヒト・動物細胞 PC-9(RCB4455) Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.
ヒト・動物細胞 PC-9(RCB4455) EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.
ヒト・動物細胞 LC-2/ad(RCB0440) , PC-9(RCB4455) , RERF-LC-KJ(RCB1313) , II-18(RCB2093) Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients.